Literature DB >> 3492589

Infection of cultured murine brain cells by Semliki Forest virus: effects of interferon-alpha beta on viral replication, viral antigen display, major histocompatibility complex antigen display and lysis by cytotoxic T lymphocytes.

A Morris, P T Tomkins, D J Maudsley, M Blackman.   

Abstract

Primary brain cell cultures prepared from newborn mice were infected with Semliki Forest virus (SFV). The effects of interferon (IFN-alpha beta) treatment on SFV replication, SFV and major histocompatibility complex (MHC) class I antigen expression, and susceptibility to lysis by SFV-specific cytotoxic T lymphocytes (CTL) were determined. The IFN-alpha beta treatment prevented replication of SFV as determined by incorporation of [3H]uridine into SFV RNA and very markedly reduced the expression of SFV antigens on the cell surface as determined by lysis with antibody and complement or indirect immunofluorescence. However, IFN-alpha beta increased expression of MHC class I antigens, measured by indirect immunofluorescence and as assessed indirectly by susceptibility to killing by alloreactive T cell lines. SFV infection had no effect on MHC class I expression in either IFN-alpha beta-treated or -untreated cells. The infected IFN-alpha beta-untreated brain cells were susceptible to killing by the CTL at effector/target ratios in the range 3 to 30. The killing was MHC antigen-restricted, and uninfected cells were not killed. A target cell (YAC) highly susceptible to natural killer cell cytotoxicity was not killed by the CTL. IFN-alpha beta treatment prior to SFV infection resulted in an augmentation of lysis by the CTL, indicating that even where SFV antigen expression is reduced, in the context of enhanced MHC class I expression brain cells remain susceptible to CTL killing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492589     DOI: 10.1099/0022-1317-68-1-99

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Interactions of interferons in the induction of histocompatibility antigens in mouse fibroblasts and glial cells.

Authors:  A G Morris; P T Tomkins
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

2.  Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I).

Authors:  T Oka; Y Ohtsuki; H Sonobe; M Furihata; I Miyoshi
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates.

Authors:  G Inchauspe; S Zebedee; D H Lee; M Sugitani; M Nasoff; A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

4.  Paralysis of street rabies virus-infected mice is dependent on T lymphocytes.

Authors:  M Sugamata; M Miyazawa; S Mori; G J Spangrude; L C Ewalt; D L Lodmell
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  Role of interferon-gamma in T-cell responses to Semliki Forest virus-infected murine brain cells.

Authors:  P T Tomkins; G A Ward; A G Morris
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

Review 6.  Cell-mediated immunity in virus infections of the central nervous system.

Authors:  P C Doherty
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

7.  Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro.

Authors:  Y Liu; N King; A Kesson; R V Blanden; A Müllbacher
Journal:  J Neuroimmunol       Date:  1989-02       Impact factor: 3.478

8.  Kirsten murine sarcoma virus abolishes interferon gamma-induced class II but not class I major histocompatibility antigen expression in a murine fibroblast line.

Authors:  D J Maudsley; A G Morris
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

Review 9.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.